NDC 31722-623
Roflumilast
Roflumilast
Roflumilast is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is Roflumilast.
| Product ID | 31722-623_eb12a013-4e61-ef1d-e053-2995a90a9a32 |
| NDC | 31722-623 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Roflumilast |
| Generic Name | Roflumilast |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-10-15 |
| Marketing Category | ANDA / |
| Application Number | ANDA208213 |
| Labeler Name | Camber Pharmaceuticals, Inc. |
| Substance Name | ROFLUMILAST |
| Active Ingredient Strength | 500 ug/1 |
| Pharm Classes | Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |